The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Platinum based Cancer Drug Market Research Report 2024
Synopsis
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
The global Platinum based Cancer Drug market was valued at US$ 1541.9 million in 2023 and is anticipated to reach US$ 1862.2 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.
Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.
Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.
This report aims to provide a comprehensive presentation of the global market for Platinum based Cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum based Cancer Drug.
Report Scope
The Platinum based Cancer Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Platinum based Cancer Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Platinum based Cancer Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
Segment by Type
Cisplatin
Oxaliplatin
Carboplatin
Others
Segment by Application
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Platinum based Cancer Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Platinum based Cancer Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
The global Platinum based Cancer Drug market was valued at US$ 1541.9 million in 2023 and is anticipated to reach US$ 1862.2 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.
Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.
Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.
This report aims to provide a comprehensive presentation of the global market for Platinum based Cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum based Cancer Drug.
Report Scope
The Platinum based Cancer Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Platinum based Cancer Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Platinum based Cancer Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
Segment by Type
Cisplatin
Oxaliplatin
Carboplatin
Others
Segment by Application
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Platinum based Cancer Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Platinum based Cancer Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Platinum based Cancer Drug Market Overview
1.1 Product Overview and Scope of Platinum based Cancer Drug
1.2 Platinum based Cancer Drug Segment by Type
1.2.1 Global Platinum based Cancer Drug Market Value Comparison by Type (2024-2030)
1.2.2 Cisplatin
1.2.3 Oxaliplatin
1.2.4 Carboplatin
1.2.5 Others
1.3 Platinum based Cancer Drug Segment by Application
1.3.1 Global Platinum based Cancer Drug Market Value by Application: (2024-2030)
1.3.2 Colorectal Cancer
1.3.3 Ovarian Cancer
1.3.4 Lung Cancer
1.3.5 Others
1.4 Global Platinum based Cancer Drug Market Size Estimates and Forecasts
1.4.1 Global Platinum based Cancer Drug Revenue 2019-2030
1.4.2 Global Platinum based Cancer Drug Sales 2019-2030
1.4.3 Global Platinum based Cancer Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Platinum based Cancer Drug Market Competition by Manufacturers
2.1 Global Platinum based Cancer Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Platinum based Cancer Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Platinum based Cancer Drug Average Price by Manufacturers (2019-2024)
2.4 Global Platinum based Cancer Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Platinum based Cancer Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Platinum based Cancer Drug, Product Type & Application
2.7 Platinum based Cancer Drug Market Competitive Situation and Trends
2.7.1 Platinum based Cancer Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Platinum based Cancer Drug Players Market Share by Revenue
2.7.3 Global Platinum based Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Platinum based Cancer Drug Retrospective Market Scenario by Region
3.1 Global Platinum based Cancer Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Platinum based Cancer Drug Global Platinum based Cancer Drug Sales by Region: 2019-2030
3.2.1 Global Platinum based Cancer Drug Sales by Region: 2019-2024
3.2.2 Global Platinum based Cancer Drug Sales by Region: 2025-2030
3.3 Global Platinum based Cancer Drug Global Platinum based Cancer Drug Revenue by Region: 2019-2030
3.3.1 Global Platinum based Cancer Drug Revenue by Region: 2019-2024
3.3.2 Global Platinum based Cancer Drug Revenue by Region: 2025-2030
3.4 North America Platinum based Cancer Drug Market Facts & Figures by Country
3.4.1 North America Platinum based Cancer Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Platinum based Cancer Drug Sales by Country (2019-2030)
3.4.3 North America Platinum based Cancer Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Platinum based Cancer Drug Market Facts & Figures by Country
3.5.1 Europe Platinum based Cancer Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Platinum based Cancer Drug Sales by Country (2019-2030)
3.5.3 Europe Platinum based Cancer Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Platinum based Cancer Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Platinum based Cancer Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Platinum based Cancer Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Platinum based Cancer Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Platinum based Cancer Drug Market Facts & Figures by Country
3.7.1 Latin America Platinum based Cancer Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Platinum based Cancer Drug Sales by Country (2019-2030)
3.7.3 Latin America Platinum based Cancer Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Platinum based Cancer Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Platinum based Cancer Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Platinum based Cancer Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Platinum based Cancer Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Platinum based Cancer Drug Sales by Type (2019-2030)
4.1.1 Global Platinum based Cancer Drug Sales by Type (2019-2024)
4.1.2 Global Platinum based Cancer Drug Sales by Type (2025-2030)
4.1.3 Global Platinum based Cancer Drug Sales Market Share by Type (2019-2030)
4.2 Global Platinum based Cancer Drug Revenue by Type (2019-2030)
4.2.1 Global Platinum based Cancer Drug Revenue by Type (2019-2024)
4.2.2 Global Platinum based Cancer Drug Revenue by Type (2025-2030)
4.2.3 Global Platinum based Cancer Drug Revenue Market Share by Type (2019-2030)
4.3 Global Platinum based Cancer Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Platinum based Cancer Drug Sales by Application (2019-2030)
5.1.1 Global Platinum based Cancer Drug Sales by Application (2019-2024)
5.1.2 Global Platinum based Cancer Drug Sales by Application (2025-2030)
5.1.3 Global Platinum based Cancer Drug Sales Market Share by Application (2019-2030)
5.2 Global Platinum based Cancer Drug Revenue by Application (2019-2030)
5.2.1 Global Platinum based Cancer Drug Revenue by Application (2019-2024)
5.2.2 Global Platinum based Cancer Drug Revenue by Application (2025-2030)
5.2.3 Global Platinum based Cancer Drug Revenue Market Share by Application (2019-2030)
5.3 Global Platinum based Cancer Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Platinum based Cancer Drug Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Hengrui Medicine
6.2.1 Hengrui Medicine Corporation Information
6.2.2 Hengrui Medicine Description and Business Overview
6.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Hengrui Medicine Platinum based Cancer Drug Product Portfolio
6.2.5 Hengrui Medicine Recent Developments/Updates
6.3 ASK Pharma
6.3.1 ASK Pharma Corporation Information
6.3.2 ASK Pharma Description and Business Overview
6.3.3 ASK Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ASK Pharma Platinum based Cancer Drug Product Portfolio
6.3.5 ASK Pharma Recent Developments/Updates
6.4 Yi Bai Pharmaceutical
6.4.1 Yi Bai Pharmaceutical Corporation Information
6.4.2 Yi Bai Pharmaceutical Description and Business Overview
6.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Product Portfolio
6.4.5 Yi Bai Pharmaceutical Recent Developments/Updates
6.5 Qilu Pharmaceutical
6.5.1 Qilu Pharmaceutical Corporation Information
6.5.2 Qilu Pharmaceutical Description and Business Overview
6.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Product Portfolio
6.5.5 Qilu Pharmaceutical Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Platinum based Cancer Drug Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Platinum based Cancer Drug Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Dr Reddy's Laboratories
6.8.1 Dr Reddy's Laboratories Corporation Information
6.8.2 Dr Reddy's Laboratories Description and Business Overview
6.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Product Portfolio
6.8.5 Dr Reddy's Laboratories Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Platinum based Cancer Drug Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Sun Pharma
6.10.1 Sun Pharma Corporation Information
6.10.2 Sun Pharma Description and Business Overview
6.10.3 Sun Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sun Pharma Platinum based Cancer Drug Product Portfolio
6.10.5 Sun Pharma Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Corporation Information
6.11.2 Novartis Platinum based Cancer Drug Description and Business Overview
6.11.3 Novartis Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Novartis Platinum based Cancer Drug Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 Debiopharm
6.12.1 Debiopharm Corporation Information
6.12.2 Debiopharm Platinum based Cancer Drug Description and Business Overview
6.12.3 Debiopharm Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Debiopharm Platinum based Cancer Drug Product Portfolio
6.12.5 Debiopharm Recent Developments/Updates
6.13 Accord Healthcare
6.13.1 Accord Healthcare Corporation Information
6.13.2 Accord Healthcare Platinum based Cancer Drug Description and Business Overview
6.13.3 Accord Healthcare Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Accord Healthcare Platinum based Cancer Drug Product Portfolio
6.13.5 Accord Healthcare Recent Developments/Updates
6.14 SK Chemicals
6.14.1 SK Chemicals Corporation Information
6.14.2 SK Chemicals Platinum based Cancer Drug Description and Business Overview
6.14.3 SK Chemicals Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.14.4 SK Chemicals Platinum based Cancer Drug Product Portfolio
6.14.5 SK Chemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Platinum based Cancer Drug Industry Chain Analysis
7.2 Platinum based Cancer Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Platinum based Cancer Drug Production Mode & Process
7.4 Platinum based Cancer Drug Sales and Marketing
7.4.1 Platinum based Cancer Drug Sales Channels
7.4.2 Platinum based Cancer Drug Distributors
7.5 Platinum based Cancer Drug Customers
8 Platinum based Cancer Drug Market Dynamics
8.1 Platinum based Cancer Drug Industry Trends
8.2 Platinum based Cancer Drug Market Drivers
8.3 Platinum based Cancer Drug Market Challenges
8.4 Platinum based Cancer Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Platinum based Cancer Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Platinum based Cancer Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Platinum based Cancer Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Platinum based Cancer Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Platinum based Cancer Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Platinum based Cancer Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Platinum based Cancer Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Platinum based Cancer Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Platinum based Cancer Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Platinum based Cancer Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Platinum based Cancer Drug, Product Type & Application
Table 12. Global Key Manufacturers of Platinum based Cancer Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Platinum based Cancer Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum based Cancer Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Platinum based Cancer Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Platinum based Cancer Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Platinum based Cancer Drug Sales Market Share by Region (2019-2024)
Table 19. Global Platinum based Cancer Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Platinum based Cancer Drug Sales Market Share by Region (2025-2030)
Table 21. Global Platinum based Cancer Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Platinum based Cancer Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Platinum based Cancer Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Platinum based Cancer Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Platinum based Cancer Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Platinum based Cancer Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Platinum based Cancer Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Platinum based Cancer Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Platinum based Cancer Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Platinum based Cancer Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Platinum based Cancer Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Platinum based Cancer Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Platinum based Cancer Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Platinum based Cancer Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Platinum based Cancer Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Platinum based Cancer Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Platinum based Cancer Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Platinum based Cancer Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Platinum based Cancer Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Platinum based Cancer Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Platinum based Cancer Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Platinum based Cancer Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Platinum based Cancer Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Platinum based Cancer Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Platinum based Cancer Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Platinum based Cancer Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Platinum based Cancer Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Platinum based Cancer Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Platinum based Cancer Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Platinum based Cancer Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Platinum based Cancer Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Platinum based Cancer Drug Sales Market Share by Type (2019-2024)
Table 53. Global Platinum based Cancer Drug Sales Market Share by Type (2025-2030)
Table 54. Global Platinum based Cancer Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Platinum based Cancer Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Platinum based Cancer Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Platinum based Cancer Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Platinum based Cancer Drug Price (USD/Unit) by Type (2019-2024)
Table 59. Global Platinum based Cancer Drug Price (USD/Unit) by Type (2025-2030)
Table 60. Global Platinum based Cancer Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Platinum based Cancer Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Platinum based Cancer Drug Sales Market Share by Application (2019-2024)
Table 63. Global Platinum based Cancer Drug Sales Market Share by Application (2025-2030)
Table 64. Global Platinum based Cancer Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Platinum based Cancer Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Platinum based Cancer Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Platinum based Cancer Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Platinum based Cancer Drug Price (USD/Unit) by Application (2019-2024)
Table 69. Global Platinum based Cancer Drug Price (USD/Unit) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Sanofi Platinum based Cancer Drug Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Hengrui Medicine Corporation Information
Table 76. Hengrui Medicine Description and Business Overview
Table 77. Hengrui Medicine Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Hengrui Medicine Platinum based Cancer Drug Product
Table 79. Hengrui Medicine Recent Developments/Updates
Table 80. ASK Pharma Corporation Information
Table 81. ASK Pharma Description and Business Overview
Table 82. ASK Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. ASK Pharma Platinum based Cancer Drug Product
Table 84. ASK Pharma Recent Developments/Updates
Table 85. Yi Bai Pharmaceutical Corporation Information
Table 86. Yi Bai Pharmaceutical Description and Business Overview
Table 87. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Yi Bai Pharmaceutical Platinum based Cancer Drug Product
Table 89. Yi Bai Pharmaceutical Recent Developments/Updates
Table 90. Qilu Pharmaceutical Corporation Information
Table 91. Qilu Pharmaceutical Description and Business Overview
Table 92. Qilu Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Qilu Pharmaceutical Platinum based Cancer Drug Product
Table 94. Qilu Pharmaceutical Recent Developments/Updates
Table 95. Teva Corporation Information
Table 96. Teva Description and Business Overview
Table 97. Teva Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Teva Platinum based Cancer Drug Product
Table 99. Teva Recent Developments/Updates
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Pfizer Platinum based Cancer Drug Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Dr Reddy's Laboratories Corporation Information
Table 106. Dr Reddy's Laboratories Description and Business Overview
Table 107. Dr Reddy's Laboratories Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Dr Reddy's Laboratories Platinum based Cancer Drug Product
Table 109. Dr Reddy's Laboratories Recent Developments/Updates
Table 110. Mylan Corporation Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Mylan Platinum based Cancer Drug Product
Table 114. Mylan Recent Developments/Updates
Table 115. Sun Pharma Corporation Information
Table 116. Sun Pharma Description and Business Overview
Table 117. Sun Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Sun Pharma Platinum based Cancer Drug Product
Table 119. Sun Pharma Recent Developments/Updates
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Novartis Platinum based Cancer Drug Product
Table 124. Novartis Recent Developments/Updates
Table 125. Debiopharm Corporation Information
Table 126. Debiopharm Description and Business Overview
Table 127. Debiopharm Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Debiopharm Platinum based Cancer Drug Product
Table 129. Debiopharm Recent Developments/Updates
Table 130. Accord Healthcare Corporation Information
Table 131. Accord Healthcare Description and Business Overview
Table 132. Accord Healthcare Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Accord Healthcare Platinum based Cancer Drug Product
Table 134. Accord Healthcare Recent Developments/Updates
Table 135. SK Chemicals Corporation Information
Table 136. SK Chemicals Description and Business Overview
Table 137. SK Chemicals Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. SK Chemicals Platinum based Cancer Drug Product
Table 139. SK Chemicals Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Platinum based Cancer Drug Distributors List
Table 143. Platinum based Cancer Drug Customers List
Table 144. Platinum based Cancer Drug Market Trends
Table 145. Platinum based Cancer Drug Market Drivers
Table 146. Platinum based Cancer Drug Market Challenges
Table 147. Platinum based Cancer Drug Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Platinum based Cancer Drug
Figure 2. Global Platinum based Cancer Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Platinum based Cancer Drug Market Share by Type in 2023 & 2030
Figure 4. Cisplatin Product Picture
Figure 5. Oxaliplatin Product Picture
Figure 6. Carboplatin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Platinum based Cancer Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Platinum based Cancer Drug Market Share by Application in 2023 & 2030
Figure 10. Colorectal Cancer
Figure 11. Ovarian Cancer
Figure 12. Lung Cancer
Figure 13. Others
Figure 14. Global Platinum based Cancer Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Platinum based Cancer Drug Market Size (2019-2030) & (US$ Million)
Figure 16. Global Platinum based Cancer Drug Sales (2019-2030) & (K Units)
Figure 17. Global Platinum based Cancer Drug Average Price (USD/Unit) & (2019-2030)
Figure 18. Platinum based Cancer Drug Report Years Considered
Figure 19. Platinum based Cancer Drug Sales Share by Manufacturers in 2023
Figure 20. Global Platinum based Cancer Drug Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Platinum based Cancer Drug Players: Market Share by Revenue in 2023
Figure 22. Platinum based Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Platinum based Cancer Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Platinum based Cancer Drug Sales Market Share by Country (2019-2030)
Figure 25. North America Platinum based Cancer Drug Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Platinum based Cancer Drug Sales Market Share by Country (2019-2030)
Figure 29. Europe Platinum based Cancer Drug Revenue Market Share by Country (2019-2030)
Figure 30. Germany Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Platinum based Cancer Drug Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Platinum based Cancer Drug Revenue Market Share by Region (2019-2030)
Figure 37. China Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Platinum based Cancer Drug Sales Market Share by Country (2019-2030)
Figure 47. Latin America Platinum based Cancer Drug Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Platinum based Cancer Drug Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Platinum based Cancer Drug Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Platinum based Cancer Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Platinum based Cancer Drug by Type (2019-2030)
Figure 57. Global Revenue Market Share of Platinum based Cancer Drug by Type (2019-2030)
Figure 58. Global Platinum based Cancer Drug Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Platinum based Cancer Drug by Application (2019-2030)
Figure 60. Global Revenue Market Share of Platinum based Cancer Drug by Application (2019-2030)
Figure 61. Global Platinum based Cancer Drug Price (USD/Unit) by Application (2019-2030)
Figure 62. Platinum based Cancer Drug Value Chain
Figure 63. Platinum based Cancer Drug Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
